SCHEMBL2934906

SCHEMBL2934906

O=C1[C@@H](Cc2ccc(O)cc2)N(Cc2ccnc3ccccc23)C(=O)N1c1ccc(S(=O)(=O)C(F)(F)F)cc1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.70
MMP2 P08253 1/20 0.36
HSD11B1 P28845 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
HDAC6 Q9UBN7 1/20 0.33
TACR1 P25103 4/20 0.33
XIAP P98170 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
SYK P43405 1/20 0.31
GAA P10253 2/20 0.31
PTPRZ1 P23471 1/20 0.31
LMNA P02545 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2934912 1.00 IGF1R (0.70) IGF1RMMP2HSD11B1PTGDR2HDAC6
Trifluoroacetic Acid SCHEMBL3724562 0.96 IGF1R (0.65) IGF1RMMP2HSD11B1PTGDR2HDAC6
Trifluoroacetic Acid SCHEMBL2935701 0.96 IGF1R (0.65) IGF1RMMP2HSD11B1PTGDR2HDAC6
SCHEMBL2931273 0.93 IGF1R (0.74) IGF1RMMP2HSD11B1PTGDR2HDAC6
SCHEMBL2931269 0.93 IGF1R (0.74) IGF1RMMP2HSD11B1PTGDR2HDAC6
Trifluoroacetic Acid SCHEMBL3739554 0.91 IGF1R (0.69) IGF1RHSD11B1PTGDR2HDAC6TACR1
SCHEMBL3724561 0.90 IGF1R (0.63) IGF1RHSD11B1PTGDR2HDAC6TACR1
SCHEMBL2940866 0.86 IGF1R (0.72) IGF1RHSD11B1PTGDR2HDAC6MAPK1
SCHEMBL2940864 0.86 IGF1R (0.72) IGF1RHSD11B1PTGDR2HDAC6MAPK1
SCHEMBL2941751 0.86 IGF1R (0.50) IGF1RHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP claimed
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed